Home
About
Overview
Sharing Data
ORCID
Help
History (45)
Simply the Best: Honoring the Outgoing Editorial Team.
motifStack for the analysis of transcription factor binding site evolution.
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.
Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3?years.
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
See All 45 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
Ahmed AR, Spigelman Z, Cavacini LA, Posner MR. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med. 2006 Oct 26; 355(17):1772-9.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Autoantibodies
B-Lymphocytes
Desmogleins
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Immunoglobulins, Intravenous
Immunologic Factors
Keratinocytes
Lymphocyte Count
Male
Middle Aged
Pemphigus
Recurrence
Remission Induction
Rituximab
authors with profiles
Lisa Ann Cavacini PhD